Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.

Eli Lilly highlighted 2025 as the rollout year for obesity drugs, with Mounjaro at the forefront of its weight-loss portfolio ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its ...

Anyone who's been prescribed a GLP-1 drug like Ozempic, Wegovy or Trulicity to treat type 2 diabetes or help them lose weight ...

Metformin is the first choice medicine for type 2 diabetes. Meglitinides can cause low blood sugar, weight gain, and headaches. Biguanides can cause stomach pain and might lead to vitamin B12 ...

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

These meds are sometimes prescribed off-label for people with overweight or obesity. Most of these diabetes drugs promote weight loss by suppressing appetite and making you feel fuller. You might have ...

Risks for kidney failure and major cardiovascular events between three GLP-1 receptor agonists were similar among veterans with diabetes. Mortality risk and certain adverse events differed between the ...

The duel of the GLP-1 data sets continues this week, with Novo issuing the latest salvo of updates on its oral obesity candidate and an Ozempic head-to-head trial win against another stalwart diabetes ...